Browse the corpus

REFERENCES Vollmer, S. AD/HD: it's not just in children. Family Practice Recertification 1998; 20:45. Wender, PH. Attention-Deficit Hyperactivity Disorder in Adults, Oxford University Press, New York 1995. Cantwell DP. Hyperactive children have grown up. What have we learned about what happens to them? Arch Gen Psychiatry 1985; 42:1026. Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry 1991; 48:77. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007; 190:402. Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009; 194:204. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006; 163:716. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999; 46:1234. Russell V, Allie S, Wiggins T. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat. Behav Brain Res 2000; 117:69. Dougherty DD, Bonab AA, Spencer TJ, et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999; 354:2132. Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21:RC121. Collaborative possibilities for molecular genetic studies of attention deficit hyperactivity disorder: report from an international conference. The ADHD Molecular Genetics Network. Am J Med Genet 2000; 96:251. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158:1052. Comings DE, Gade-Andavolu R, Gonzalez N, et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 2000; 57:178.

Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158:1052. Comings DE, Gade-Andavolu R, Gonzalez N, et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 2000; 57:178. Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 1999; 174:105. Manor I, Tyano S, Eisenberg J, et al. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry 2002; 7:790. Seidman LJ, Biederman J, Weber W, et al. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44:260. Alpert JE, Maddocks A, Nierenberg AA, et al. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 1996; 62:213. Faraone SV, Biederman J, Spencer T, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006; 163:1720. McGough JJ, McCracken JT. Adult attention deficit hyperactivity disorder: moving beyond DSM-IV. Am J Psychiatry 2006; 163:1673. Faraone SV, Wilens TE, Petty C, et al. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict 2007; 16 Suppl 1:24. Barkley, RA. AD/HD and the Nature of Self-Control, Guilford, New York 1997. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997; 121:65. Ossmann JM, Mulligan NW. Inhibition and attention deficit hyperactivity disorder in adults. Am J Psychol 2003; 116:35. Silver, LB. Attention-deficit/hyperactivity disorder in adult life. Child Adoles Psychiatr Clin North Am 2000; 9:521. Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 2006; 163:1730. Donnelly CL. History and pathophysiology of ADHD. CNS Spectr 2006; 11:4.

Silver, LB. Attention-deficit/hyperactivity disorder in adult life. Child Adoles Psychiatr Clin North Am 2000; 9:521. Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 2006; 163:1730. Donnelly CL. History and pathophysiology of ADHD. CNS Spectr 2006; 11:4. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry 2000; 157:1156. Shaffer D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry 1994; 151:633. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150:885. Mannuzza S, Klein RG, Klein DF, et al. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry 2002; 159:1882. Zucker M, Morris MK, Ingram SM, et al. Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. Psychol Assess 2002; 14:379. Young, S. The YAQ-S and YAQ-1: The development of self and informant questionnaires reporting on current adult ADHD symptomatology, comorbid and associated problems. Personality and Individual Differences 2004; 36:1211. Sandra Kooij JJ, Marije Boonstra A, Swinkels SH, et al. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord 2008; 11:445. Fargason RE, Ford CV. Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis. South Med J 1994; 87:302. Nahlik, JE, Searight, HR. Diagnosis and treatment of attention deficit hyperactivity disorder. Primary Care Reports 1996; 2:65. Brown, TE. Brown Attention Deficit Disorders Scales Manual. San Antonio, TX, Psychological Corporation, 1996. Copeland, ED. Medications for Attention Disorders and Related Medical Problems, SPI Press, Atlanta, GA 1991. Conners, CK, Erhardt, et al. Conners' Adult ADHD Rating Scales (CAARS), Multihealth Systems, Inc., New York 1999. World Health Organization. ASRS-VI.I Screener 2003.

Brown, TE. Brown Attention Deficit Disorders Scales Manual. San Antonio, TX, Psychological Corporation, 1996. Copeland, ED. Medications for Attention Disorders and Related Medical Problems, SPI Press, Atlanta, GA 1991. Conners, CK, Erhardt, et al. Conners' Adult ADHD Rating Scales (CAARS), Multihealth Systems, Inc., New York 1999. World Health Organization. ASRS-VI.I Screener 2003. McCann BS, Scheele L, Ward N, Roy-Byrne P. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 2000; 12:240. Sachs GS, Baldassano CF, Truman CJ, Guille C. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 2000; 157:466. Wilens TE. Attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry 2006; 163:2059. Shekim WO, Asarnow RF, Hess E, et al. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 1990; 31:416. McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 2005; 162:1621. Barkley, RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 2nd, Guilford, New York. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, DC 1994. Naseem S, Chaudhary B, Collop N. Attention deficit hyperactivity disorder in adults and obstructive sleep apnea. Chest 2001; 119:294. Ball, JD, Wooten, V, Crowell, TA. Adult ADHD and/or sleep apnea? Differential diagnostic considerations with six case studies. J Clin Psychol Med Settings 1999; 6:259. Okie S. ADHD in adults. N Engl J Med 2006; 354:2637. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153:1147. Wilens, TE, Spencer, et al. Phamacotherapy of adult ADHD. In: Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment, 2nd ed, Barakley, RA (Eds), Guilford, New York 1998. p.592.

Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153:1147. Wilens, TE, Spencer, et al. Phamacotherapy of adult ADHD. In: Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment, 2nd ed, Barakley, RA (Eds), Guilford, New York 1998. p.592. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56:1073. Jadad AR, Boyle M, Cunningham C, et al. Treatment of attention-deficit/hyperactivity disorder, Agency for Healthcare Research and Quality, Rockville, MD 2000. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis 2000; 188:230. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998; 279:1100. Lutton ME, Leach L, Triezenberg D. Clinical inquiries. Does stimulant therapy help adult ADHD? J Fam Pract 2003; 52:888. Schweitzer JB, Cummins TK, Kant CA. Attention-deficit/hyperactivity disorder. Med Clin North Am 2001; 85:757. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001; 58:775. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord 2002; 5:189. Spencer T, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:434. Drugs for treatment of ADHD. Treat Guidel Med Lett 2006; 4:77. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann N Y Acad Sci 2001; 931:1. Paterson R, Douglas C, Hallmayer J, et al. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 1999; 33:494.

Drugs for treatment of ADHD. Treat Guidel Med Lett 2006; 4:77. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann N Y Acad Sci 2001; 931:1. Paterson R, Douglas C, Hallmayer J, et al. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 1999; 33:494. Lisdexamfetamine dimesylate (Vyvanse) for ADHD. Med Lett Drugs Ther 2007; 49:58. Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 1999; 340:780. Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354:1445. Wilens TE, Hammerness PG, Biederman J, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2005; 66:253. Spencer TJ, Biederman J, Wilen T. of ADHD with antidepressants. In: Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment, 2nd ed, Barkley RA (Ed), Guilford, New York 1998. p.522. Wender PH. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 1998; 59 Suppl 7:76. Vastag B. Pay attention: ritalin acts much like cocaine. JAMA 2001; 286:905. Manufacturer's prescribing information for lisdexamfetamine. www.vyvanse.com/pdf/prescribing_information.pdf. Spencer, TJ, Biederman, J, Wilen, T. Pharmacotherapy of ADHD with antidepressants. In: Barkley, RA (ed), Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment, 2nd ed, New York, Guilford, 1998, p. 522. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158:282. Wilens TE, Haight BR, Horrigan JP, et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry 2005; 57:793. Strattera, package insert, Eli Lilly and Company, November, 2002. www.fda.gov/medwatch/safety/2005/safety05.htm#Strattera (Accessed October 5, 2005). Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003; 53:112. New warning for strattera. FDA Talk Paper, December 17, 2004, www.fda.gov/bbs/topics/ANSWERS/2004/ANS01335.html (Accessed 3/7/05).

www.fda.gov/medwatch/safety/2005/safety05.htm#Strattera (Accessed October 5, 2005). Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003; 53:112. New warning for strattera. FDA Talk Paper, December 17, 2004, www.fda.gov/bbs/topics/ANSWERS/2004/ANS01335.html (Accessed 3/7/05). Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:1551. Arnold LE. Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Ann N Y Acad Sci 2001; 931:310. Higgins ES. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. J Fam Pract 1999; 48:15. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111:179. Biederman J, Monuteaux MC, Spencer T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 2008; 165:597. Volkow ND, Swanson JM. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? Am J Psychiatry 2008; 165:553. Mannuzza S, Klein RG, Truong NL, et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 2008; 165:604. Safren SA, Otto MW, Sprich S, et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005; 43:831. Stevenson CS, Whitmont S, Bornholt L, et al. A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust N Z J Psychiatry 2002; 36:610. Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010; 304:875. Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010; 167:958.

Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010; 304:875. Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010; 167:958. Searight, HR. Marriage and Intimacy. In: Jones, CB, Searight, HR, Urban, M (eds), Parent Articles on AD/HD, San Antonio, TX, Communication Skill Builders 1999. p.186. Searight HR, Burke JM, Rottnek F. Adult ADHD: evaluation and treatment in family medicine. Am Fam Physician 2000; 62:2077. Topic 1232 Version 7.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1104-115.66.252.144-FC8D04C3D0-S244013.14]